The FDA announced that more than 233,003 bottles of duloxetine were recalled on November 19 after finding the capsules contained high levels of N-nitroso-duloxetine.
The FDA announced that more than 233,003 bottles of duloxetine were recalled on November 19 after finding the capsules contained high levels of N-nitroso-duloxetine.